Table 1.
Characteristics of Patient Participants by Prognosis Level (N = 34)
| Level |
p | |||
|---|---|---|---|---|
| None (n = 10) | Low (n = 14) | High (n = 10) | ||
| Age in years, median (range) | 59.9 (36.3–72.5) | 70.6 (37.9–86.3) | 67.5 (40.4–83.0) | 0.19 |
| Gender, n (%) | 0.44 | |||
| Female | 5 (50) | 8 (57) | 8 (80) | |
| Race, n (%) | 1 | |||
| Black/African American | 1 (10) | 1 (7) | 0 (0) | |
| White | 8 (80) | 11 (79) | 9 (90) | |
| Other | 1 (10) | 2 (14) | 1 (10) | |
| Hispanic or Latino ethnicity, n (%) | 0.77 | |||
| Yes | 1 (10) | 2 (14) | 0 (0) | |
| Highest education, n (%) | 0.96 | |||
| ≥Bachelors | 2 (20) | 4 (29) | 2 (20) | |
| High school/some college | 7 (70) | 8 (57) | 7 (70) | |
| ≤High school | 1 (10) | 2 (14) | 1 (10) | |
| Financial security, n (%) | 0.15 | |||
| Secure | 2 (20) | 8 (62) | 6 (60) | |
| Partially secure | 7 (70) | 5 (38) | 4 (40) | |
| Insecure | 1 (10) | 0 (0) | 0 (0) | |
| Cancer type, n (%) | 0.55 | |||
| Lung | 3 (30) | 1 (7) | 1 (10) | |
| Gastrointestinal (non-CRC) | 0 (0) | 3 (21) | 1 (10) | |
| CRC/breast/prostate | 3 (30) | 5 (36) | 2 (20) | |
| Other | 4 (40) | 5 (36) | 6 (60) | |
| Palliative Performance Scale, median (range) | 5.5 (3–9) | 4.5 (1–8) | 4.5 (1–8) | 0.29 |
| Clinicians' estimate of survival time, n (%) | 0.53 | |||
| <2 Weeks | 0 (0) | 3 (21) | 2 (20) | |
| 2 Weeks to <3 months | 4 (40) | 3 (21) | 4 (40) | |
| ≥3 Months | 6 (60) | 8 (57) | 4 (40) | |
| Days from enrollment to death, median (range) | 27.5 (2–125) | 12 (0–142) | 31.5 (1–157) | 0.44 |
For statistical significance testing purposes, we used Fisher's exact test for categorical data and Kruskal–Wallis test for continuous data.
CRC, colorectal cancer.